6550--Blood Type IVD Reagents

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

262-NETWORK CONTRACT OFFICE 22 (36C262)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C26227Q0043

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents4
The Department of Veterans Affairs, through its 262-Network Contract Office 22, has issued a Combined Synopsis/Solicitation (Procurement Identifier: 36C26227Q0043) for the supply of Blood Type In-Vitro Diagnostic (IVD) Reagents. This procurement seeks to secure reliable sources for reagents essential to blood typing and related diagnostic procedures, supporting the critical healthcare needs of veterans served by the Department. The scope of this solicitation encompasses the manufacturing and delivery of IVD reagents specifically designed for blood typing applications. These reagents are vital for ensuring accurate blood group determination, which is fundamental to safe transfusion practices and overall patient care within VA medical facilities. The intended outcome is to establish a dependable supply chain for high-quality diagnostic substances that meet the rigorous standards required in clinical laboratory environments. Key requirements for this procurement include compliance with the North American Industry Classification System (NAICS) code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing. Contractors must demonstrate the capability to produce and deliver reagents that adhere to all applicable regulatory and quality standards for medical diagnostics. The Product Service Code (PSC) associated with this opportunity is 6550, further specifying the focus on medical and surgical instruments, equipment, and supplies. The contracting activity is managed by the 262-Network Contract Office 22, a federal office within the Department of Veterans Affairs. Interested parties should direct all inquiries and submissions to the primary point of contact, Marcos Diaz, via email at [email protected]. The solicitation was posted on October 30, 2026, with responses due by November 16, 2026. This opportunity is classified as a Combined Synopsis/Solicitation, streamlining the procurement process by combining the synopsis and solicitation phases. Contractors should review all attached documents for detailed specifications, submission instructions, and any special considerations or set-aside requirements, as these are not explicitly detailed in the notice summary. Contractors with expertise in the manufacturing of in-vitro diagnostic substances, particularly those with experience supplying blood typing reagents to healthcare institutions, are encouraged to evaluate this opportunity. The procurement is expected to remain consistent in its core requirements throughout the contract lifecycle, focusing on the reliable provision of high-quality IVD reagents to support the Department of Veterans Affairs’ mission of delivering exemplary care to veterans. For further details and to access the full solicitation and attachments, interested vendors should visit the official SAM.gov opportunity page at: https://sam.gov/opp/3cc7475324074dc484f36a44f0cbe2fa/view.